1000+ types of tissue microarray

TISSUE ARRAYS

B-24End-3b	Endometrium cancer tissue array with matched cancer adjacent endometrium tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing UT243a
Cores	24	Cases	12
Row number	4	Column number	6
Core Diameter(mm)	2.0	Thickness(µm)	5.0
Tissue Array Type	FFPE	Species	Human
QA/QC	H&E and IHC confirmed
Applications	Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page.
Notes	1.Please keep the slides at 4 ℃ after receiving, and make experiment within 3 months will be better. 2.Bake the slides for 60 minutes at 65℃ before the experiment. 3.Please choose a gentle repair method to avoid tissue detachment.

Legend:

Ute

-Uterus

AT (*)

Malignant (I)

Malignant (IB)

Malignant (IC)

Malignant (IIA)

TISSUE ARRAYS B-24End-3b

	1	2	3	4	5	6
A	UTE	UTE	UTE	UTE	UTE	UTE
B	UTE	UTE	UTE	UTE	UTE	UTE
C	UTE	UTE	UTE	UTE	UTE	UTE
D	UTE	UTE	UTE	UTE	UTE	UTE

Pos	No	Age	Sex	Organ_Anatomic_Site	Pathology_diagnosis	Grade	TNM	Stage	Type
A1	1	57	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant
A2	2	57	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
A3	3	61	F	Uterus	Endometrioid adenocarcinoma	1	T1N0M0	I	Malignant
A4	4	61	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
A5	5	43	F	Uterus	Endometrioid adenocarcinoma	2	T1N0M0	I	Malignant
A6	6	43	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
B1	7	48	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant
B2	8	48	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
B3	9	70	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant
B4	10	70	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
B5	11	70	F	Uterus	Endometrioid adenocarcinoma	1	T2aN0M0	IIA	Malignant
B6	12	70	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
C1	13	58	F	Uterus	Endometrioid adenocarcinoma	1	T1bN0M0	IB	Malignant
C2	14	58	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
C3	15	52	F	Uterus	Endometrioid adenocarcinoma	2	T1cN0M0	IC	Malignant
C4	16	52	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
C5	17	48	F	Uterus	Endometrioid adenocarcinoma	2	T1cN0M0	IC	Malignant
C6	18	48	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
D1	19	52	F	Uterus	Endometrioid adenocarcinoma	2--3	T1bN0M0	IB	Malignant
D2	20	52	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
D3	21	61	F	Uterus	Endometrioid adenocarcinoma	2--3	T1bN0M0	IB	Malignant
D4	22	61	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
D5	23	53	F	Uterus	Endometrioid adenocarcinoma	3	T1bN0M0	IB	Malignant
D6	24	53	F	Uterus	Cancer adjacent tissue (endometrium tissue)	*	*	*	AT
E1	25